Phase I Study of KW-0761 in Relapsed Patients With CCR4-Positive ATL and PTCL

NCT00355472 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Adult T-Cell Leukemia and Lymphoma (ATL)
Adult Peripheral T-Cell Lymphoma (PTCL)

Interventions

DRUG: KW-0761

Sponsor

Kyowa Kirin Co., Ltd.